{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,6,28]],"date-time":"2024-06-28T00:23:34Z","timestamp":1719534214806},"reference-count":21,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,6,27]]},"DOI":"10.7759\/cureus.63272","type":"journal-article","created":{"date-parts":[[2024,6,27]],"date-time":"2024-06-27T10:55:52Z","timestamp":1719485752000},"source":"Crossref","is-referenced-by-count":0,"title":["A Case of New-Onset Atrial Tachyarrhythmias With Apical Hypertrophic Cardiomyopathy and Bronchiectasis in a Very Elderly Patient: A Therapeutic Dilemma"],"prefix":"10.7759","author":[{"given":"Satoshi","family":"Kurisu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hitoshi","family":"Fujiwara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1253\/circj.CJ-20-0910","article-title":"JCS\/JHFS 2018 Guideline on the Diagnosis and Treatment of Cardiomyopathies","volume":"85","author":"Kitaoka H","year":"2021","unstructured":"Kitaoka H, Tsutsui H, Kubo T, et al.. JCS\/JHFS 2018 Guideline on the Diagnosis and Treatment of Cardiomyopathies. Circ J. 2021, 85:1590-689. 10.1253\/circj.CJ-20-0910","journal-title":"Circ J"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1253\/circj.CJ-17-0845","article-title":"Patients' Characteristics and clinical course of hypertrophic cardiomyopathy in a regional Japanese cohort - results from Kochi RYOMA study","volume":"82","author":"Kubo T","year":"2018","unstructured":"Kubo T, Hirota T, Baba Y, et al.. Patients' Characteristics and clinical course of hypertrophic cardiomyopathy in a regional Japanese cohort - results from Kochi RYOMA study. Circ J. 2018, 82:824-30. 10.1253\/circj.CJ-17-0845","journal-title":"Circ J"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/s0735-1097(01)01778-8","article-title":"Long-term outcome in patients with apical hypertrophic cardiomyopathy","volume":"39","author":"Eriksson MJ","year":"2002","unstructured":"Eriksson MJ, Sonnenberg B, Woo A, Rakowski P, Parker TG, Wigle ED, Rakowski H. Long-term outcome in patients with apical hypertrophic cardiomyopathy. J Am Coll Cardiol. 2002, 39:638-45. 10.1016\/s0735-1097(01)01778-8","journal-title":"J Am Coll Cardiol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1093\/ehjci\/jev192","article-title":"Differences in apical and non-apical types of hypertrophic cardiomyopathy: a prospective analysis of clinical, echocardiographic, and cardiac magnetic resonance findings and outcome from 350 patients","volume":"17","author":"Kim EK","year":"2016","unstructured":"Kim EK, Lee SC, Hwang JW, et al.. Differences in apical and non-apical types of hypertrophic cardiomyopathy: a prospective analysis of clinical, echocardiographic, and cardiac magnetic resonance findings and outcome from 350 patients. Eur Heart J Cardiovasc Imaging. 2016, 17:678-86. 10.1093\/ehjci\/jev192","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.hjc.2023.02.004","article-title":"Prevalence, characteristics, and natural history of apical phenotype in a large cohort of patients with hypertrophic cardiomyopathy","volume":"73","author":"Rouskas P","year":"2023","unstructured":"Rouskas P, Zegkos T, Ntelios D, et al.. Prevalence, characteristics, and natural history of apical phenotype in a large cohort of patients with hypertrophic cardiomyopathy. Hellenic J Cardiol. 2023, 73:8-15. 10.1016\/j.hjc.2023.02.004","journal-title":"Hellenic J Cardiol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1136\/heartjnl-2016-310720","article-title":"Impact of atrial fibrillation on the clinical course of apical hypertrophic cardiomyopathy","volume":"103","author":"Lee SE","year":"2017","unstructured":"Lee SE, Park JK, Uhm JS, Kim JY, Pak HN, Lee MH, Joung B. Impact of atrial fibrillation on the clinical course of apical hypertrophic cardiomyopathy. Heart. 2017, 103:1496-501. 10.1136\/heartjnl-2016-310720","journal-title":"Heart"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1002\/ehf2.13563","article-title":"Clinical significance of new-onset atrial fibrillation in patients with hypertrophic cardiomyopathy","volume":"8","author":"Kubo T","year":"2021","unstructured":"Kubo T, Baba Y, Ochi Y, et al.. Clinical significance of new-onset atrial fibrillation in patients with hypertrophic cardiomyopathy. ESC Heart Fail. 2021, 8:5022-30. 10.1002\/ehf2.13563","journal-title":"ESC Heart Fail"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.4022\/jafib.2207","article-title":"Thromboembolic outcomes of different anticoagulation strategies for patients with atrial fibrillation in the setting of hypertrophic cardiomyopathy: a systematic review","volume":"12","author":"Lozier MR","year":"2019","unstructured":"Lozier MR, Sanchez AM, Lee JJ, Donath EM, Font VE, Escolar E. Thromboembolic outcomes of different anticoagulation strategies for patients with atrial fibrillation in the setting of hypertrophic cardiomyopathy: a systematic review. J Atr Fibrillation. 2019, 12:2207. 10.4022\/jafib.2207","journal-title":"J Atr Fibrillation"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201203-0487OC","article-title":"Short- and long-term antibiotic treatment reduces airway and systemic inflammation in non-cystic fibrosis bronchiectasis","volume":"186","author":"Chalmers JD","year":"2012","unstructured":"Chalmers JD, Smith MP, McHugh BJ, Doherty C, Govan JR, Hill AT. Short- and long-term antibiotic treatment reduces airway and systemic inflammation in non-cystic fibrosis bronchiectasis. Am J Respir Crit Care Med. 2012, 186:657-65. 10.1164\/rccm.201203-0487OC","journal-title":"Am J Respir Crit Care Med"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2016.10.055","article-title":"Adult patients with bronchiectasis: a first look at the US Bronchiectasis Research Registry","volume":"151","author":"Aksamit TR","year":"2017","unstructured":"Aksamit TR, O'Donnell AE, Barker A, et al.. Adult patients with bronchiectasis: a first look at the US Bronchiectasis Research Registry. Chest. 2017, 151:982-92. 10.1016\/j.chest.2016.10.055","journal-title":"Chest"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1186\/s12890-022-02006-x","article-title":"A retrospective analysis of risk factors for massive hemoptysis in patients with bronchiectasis","volume":"22","author":"Luo L","year":"2022","unstructured":"Luo L, Luo J, Jiang Y. A retrospective analysis of risk factors for massive hemoptysis in patients with bronchiectasis. BMC Pulm Med. 2022, 22:214. 10.1186\/s12890-022-02006-x","journal-title":"BMC Pulm Med"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1002\/ejhf.316","article-title":"Prediction of thrombo-embolic risk in patients with hypertrophic cardiomyopathy (HCM Risk-CVA)","volume":"17","author":"Guttmann OP","year":"2015","unstructured":"Guttmann OP, Pavlou M, O'Mahony C, et al.. Prediction of thrombo-embolic risk in patients with hypertrophic cardiomyopathy (HCM Risk-CVA). Eur J Heart Fail. 2015, 17:837-45. 10.1002\/ejhf.316","journal-title":"Eur J Heart Fail"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1253\/circj.CJ-19-0186","article-title":"Clinical profile of thromboembolic events in patients with hypertrophic cardiomyopathy in a regional Japanese cohort - results from Kochi RYOMA study","volume":"83","author":"Hirota T","year":"2019","unstructured":"Hirota T, Kubo T, Baba Y, et al.. Clinical profile of thromboembolic events in patients with hypertrophic cardiomyopathy in a regional Japanese cohort - results from Kochi RYOMA study. Circ J. 2019, 83:1747-54. 10.1253\/circj.CJ-19-0186","journal-title":"Circ J"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2006.03.012","article-title":"Characterisation of the onset and presenting clinical features of adult bronchiectasis","volume":"100","author":"King PT","year":"2006","unstructured":"King PT, Holdsworth SR, Freezer NJ, Villanueva E, Holmes PW. Characterisation of the onset and presenting clinical features of adult bronchiectasis. Respir Med. 2006, 100:2183-9. 10.1016\/j.rmed.2006.03.012","journal-title":"Respir Med"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2013-201001","article-title":"Massive haemoptysis following dabigatran administration in a patient with bronchiectasis","volume":"2014","author":"Hayama M","year":"2014","unstructured":"Hayama M, Inoue H, Wada H, Mio T. Massive haemoptysis following dabigatran administration in a patient with bronchiectasis. BMJ Case Rep. 2014, 2014:bcr2013201001. 10.1136\/bcr-2013-201001","journal-title":"BMJ Case Rep"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/s0002-9149(84)80212-x","article-title":"Amiodarone for long-term management of patients with hypertrophic cardiomyopathy","volume":"54","author":"McKenna WJ","year":"1984","unstructured":"McKenna WJ, Harris L, Rowland E, Kleinebenne A, Krikler DM, Oakley CM, Goodwin JF. Amiodarone for long-term management of patients with hypertrophic cardiomyopathy. Am J Cardiol. 1984, 54:802-10. 10.1016\/s0002-9149(84)80212-x","journal-title":"Am J Cardiol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/s0735-1097(10)80014-2","article-title":"Atrial fibrillation in hypertrophic cardiomyopathy: a longitudinal study","volume":"15","author":"Robinson K","year":"1990","unstructured":"Robinson K, Frenneaux MP, Stockins B, Karatasakis G, Poloniecki JD, McKenna WJ. Atrial fibrillation in hypertrophic cardiomyopathy: a longitudinal study. J Am Coll Cardiol. 1990, 15:1279-85. 10.1016\/s0735-1097(10)80014-2","journal-title":"J Am Coll Cardiol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1378\/chest.123.2.646","article-title":"Pulmonary toxicity in patients receiving low-dose amiodarone","volume":"123","author":"Ott MC","year":"2003","unstructured":"Ott MC, Khoor A, Leventhal JP, Paterick TE, Burger CD. Pulmonary toxicity in patients receiving low-dose amiodarone. Chest. 2003, 123:646-51. 10.1378\/chest.123.2.646","journal-title":"Chest"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/0735-1097(95)00229-W","article-title":"Salutary effect of disopyramide on left ventricular diastolic function in hypertrophic obstructive cardiomyopathy","volume":"26","author":"Matsubara H","year":"1995","unstructured":"Matsubara H, Nakatani S, Nagata S, Ishikura F, Katagiri Y, Ohe T, Miyatake K. Salutary effect of disopyramide on left ventricular diastolic function in hypertrophic obstructive cardiomyopathy. J Am Coll Cardiol. 1995, 26:768-75. 10.1016\/0735-1097(95)00229-W","journal-title":"J Am Coll Cardiol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1161\/01.cir.96.5.1520","article-title":"Class Ia antiarrhythmic drug cibenzoline: a new approach to the medical treatment of hypertrophic obstructive cardiomyopathy","volume":"96","author":"Hamada M","year":"1997","unstructured":"Hamada M, Shigematsu Y, Ikeda S, et al.. Class Ia antiarrhythmic drug cibenzoline: a new approach to the medical treatment of hypertrophic obstructive cardiomyopathy. Circulation. 1997, 96:1520-4. 10.1161\/01.cir.96.5.1520","journal-title":"Circulation"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.21101","article-title":"Hypertrophic cardiomyopathy and atrial fibrillation: a review","volume":"14","author":"Palyam V","year":"2022","unstructured":"Palyam V, Azam AT, Odeyinka O, Alhashimi R, Thoota S, Ashok T, Sange I. Hypertrophic cardiomyopathy and atrial fibrillation: a review. Cureus. 2022, 14:e21101. 10.7759\/cureus.21101","journal-title":"Cureus"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/247509-a-case-of-new-onset-atrial-tachyarrhythmias-with-apical-hypertrophic-cardiomyopathy-and-bronchiectasis-in-a-very-elderly-patient-a-therapeutic-dilemma","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,27]],"date-time":"2024-06-27T10:55:55Z","timestamp":1719485755000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/247509-a-case-of-new-onset-atrial-tachyarrhythmias-with-apical-hypertrophic-cardiomyopathy-and-bronchiectasis-in-a-very-elderly-patient-a-therapeutic-dilemma"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,27]]},"references-count":21,"URL":"https:\/\/doi.org\/10.7759\/cureus.63272","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6,27]]}}}